Cell Therapy Raw Materials Market Growth, Insights and Key Players
The global market for cell therapy raw materials is projected to grow from US$ 5.43 billion in 2024 to US$ 6.75 billion in 2025, reaching US$ 48.54 billion by 2034, with a CAGR of 24.5%. This growth is driven by the increasing demand for cell therapies to treat diseases like cancer, rare diseases, and genetic disorders.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5399
Market Overview
Raw materials in cell therapy include substances like cell isolation reagents, culture media, and disposables used in production but not included in the final product. The choice of materials impacts the safety, effectiveness, and regulatory approval of therapies. High-quality raw materials can accelerate development, reduce costs, and ensure consistency, as the field of cell and gene therapy continues to expand.
Leading Companies in the Cell Therapy Raw Materials Market
- Thermo Fisher Scientific Inc.
Thermo Fisher Scientific is a global leader in laboratory products and services, offering a wide range of cell therapy raw materials, including culture media, reagents, and cryopreservation solutions. The company’s expertise in biotechnology and its robust portfolio of cell therapy products make it a key player in the industry. - Merck KGaA
Merck KGaA is a multinational pharmaceutical and life sciences company providing essential raw materials for cell therapies. They offer a variety of products, such as cell culture media, growth factors, and reagents, critical for the development and manufacturing of cell-based therapies. - Danaher
Danaher, a global science and technology innovator, supplies a wide range of biotechnology solutions, including tools and raw materials used in cell therapy production. Their expertise spans cell culture, bioprocessing, and analytical instruments, making them a significant player in this market. - Sartorius Stedim Biotech
Sartorius is a leading supplier of equipment and consumables for bioprocessing, including raw materials for cell therapy. Their products, such as cell culture media and filtration systems, support the efficient and scalable production of cell therapies. - Actylis
Actylis is known for its wide range of chemical and biological products used in biotechnology, including cell therapy. They specialize in the supply of cell culture media, reagents, and other raw materials that support cell-based research and therapy development. - ACROBiosystems
ACROBiosystems provides high-quality proteins, growth factors, and reagents essential for cell therapy research and development. Their specialized offerings play a critical role in the development and production of innovative cell and gene therapies. - STEMCELL Technologies
STEMCELL Technologies is a leading supplier of cell culture media, reagents, and tools used in cell therapy. They focus on providing high-quality, standardized products for stem cell research, regenerative medicine, and therapeutic applications. - Grifols, S.A.
Grifols is a global healthcare company that manufactures plasma-derived therapies and biotechnological products. The company also supplies cell therapy raw materials, including culture media and reagents, to support the development of cellular and gene therapies. - Charles River Laboratories
Charles River Laboratories is known for offering a wide range of services and raw materials for cell therapy. Their offerings include cell culture media, bioprocessing tools, and reagents, essential for the development and manufacturing of cell-based therapies. - RoosterBio, Inc.
RoosterBio focuses on providing high-quality human stem cell products and raw materials for regenerative medicine. They offer cell culture media, reagents, and growth factors to support the production of scalable and reproducible cell therapies. - PromoCell GmbH
PromoCell is a well-established provider of cell culture media, reagents, and cell-based products. Their offerings play a significant role in the manufacturing process of cell therapies, particularly in the production of stem cells and other cell-based therapies.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/cell-therapy-raw-materials-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5399
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
